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Abstract. Intestinal infection with Salmonella enterica serotype 
Enteritidis, a food-borne infection spread to humans especially 
through contaminated eggs and egg-products as well as 
undercooked contaminated fresh meat, is the most common cause 
of intestinal inflammation in the European Union. Enteritis caused 
by Salmonella Enteritidis is characterized by fever, diarrhoea and 
abdominal pain. The disruption of the intestinal epithelial barrier 
function contributes to diarrhoea and is responsible for the 
perpetuation of the inflammatory process. In this sense, oxidative 
stress and the proinflammatory cytokines TNF-α, IFN-γ and IL-1β 
are described to induce the disorganization of the tight junctions 
(TJ), the most apical epithelial intercellular junctions and 
responsible for the paracellular permeability. The interest of this 
chapter relies not only in the investigation dealing with the 
mechanisms of TJ regulation but also in the contribution to the 
development of new tools for the prevention of epithelial barrier 
disruption in enteritis caused by Salmonella Enteritidis.  
 
Introduction 
   
      Salmonella are gram-negative bacteria consisting of non-spore forming bacilli 
and are a member of the family Enterobacteriaceae. The genus Salmonella 
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includes two species, Salmonella enterica and Salmonella bongori. The 
nomenclature of Salmonella is quite complex and is based on both serotype 
and subspecies names [1]. For the subspecies enterica of Salmonella 
enterica, more than 2500 serotypes have been described [2]. Thus, 
Salmonella enterica subspecies enterica serotype Enteritidis is shortened to 
Salmonella serotype Enteritidis or Salmonella Enteritidis. Salmonella 
Enteritidis is one of the leading causes of food-borne salmonellosis in 
humans all over the world [3]. The remaining cases of salmonellosis are 
caused by Salmonella enterica serotype Typhimurium, associated with the 
consumption of contaminated pig and beef meat, and other more minor 
serotypes. Poultry is considered the single largest reservoir of Salmonella 
Enteritidis and the consumption of chicken meat and egg products is the 
major source of human infection [4-7]. Salmonella causes asymptomatic 
intestinal infections in adult birds but acute outbreaks exhibiting clinical 
disease along with high levels of mortality occur in chicks younger than                  
2 weeks old [8]. Birds that are asymptomatic carriers may facilitate the 
spread of disease infections among flock, thus constituting the major source 
of infection [9,10]. Salmonellosis is characterized by fever, diarrhea and 
abdominal cramps, but if the bacterium invades the bloodstream it can also 
cause life-threatening infections. 
 A necessary step in the successful colonization and ultimate production 
of disease is the ability of bacterial pathogens to adhere to host surfaces, 
which is an important determinant of virulence. Generally, binding to 
intestinal host cells is essential for the bacteria to resist the fluid flow of the 
luminal contents and the peristalsis of intestinal contraction. Once bound to 
the epithelial surface, bacteria may colonize and establish a permanent 
residence in the gut. The host cell is often an active participant in the 
adhesion process and does not function simply as an inert surface for 
attachment. Indeed, a wide range of mammalian cell surface constituents, 
including glycoproteins and glycolipids, can serve as receptors for bacterial 
attachment [11]. Salmonella Enteritidis possesses mannose-specific lectins in 
type-1 fimbriae that adhere to glycoproteins of the intestinal epithelium [12] 
and allow passage, mainly but not exclusively, through M cells (microfold 
cells) [13] (Fig. 1). This invasive mechanism is governed by the type III 
secretion system 1 (T3SS-1), which facilitates epithelial uptake and invasion 
[14]. The genes that encode the T3SS-1 machinery are associated with 
Salmonella pathogenicity island 1 (SPI-1) [15]. Pathogenicity islands (PI) are 
genetic elements that carry genes encoding virulence factors, such as 
adhesion, invasion, and toxin genes [16,17]. In fact, one of the major                     
clinical features of salmonellosis is diarrhea, which is caused by SPI-1 T3SS  
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Figure 1. Salmonella Enteritidis entry into intestinal epithelial cells, mainly via M 
cells. After crossing the M cell, the bacteria are engulfed by macrophages and induce 
their apoptotic death. This process allows the bacteria to invade adjacent epithelial 
cells and to elicit an inflammatory response. 
 
translocated proteins [18]. A number of additional proteins are translocated 
via the SPI-1 T3SS including SipA, SipC, and SopB (SigD), which interact 
with the actin cytoskeleton causing cytoskeletal rearrangements leading to 
membrane ruffling [19,20]. Membrane ruffling is characterized by a 
rearrangement of the cell membrane and cytosol such that the Salmonella is 
surrounded by the host cell and internalized within a membrane containing 
vacuole that serves as a protective niche from lysosomal degradation [21,22].  
 
1. Intestinal epithelial barrier function  
 
 The gastrointestinal epithelium is a selective barrier that allows the 
absorption of nutrients, electrolytes and water, but restricts the passage of 
larger potentially injurious compounds such as allergens, toxins and 
pathogens. Thus, this barrier prevents inflammation, mucosal injury, bacterial 
translocation and systemic infection. The epithelial cells create this selective 
permeability, constituting the so called epithelial barrier function, by two 
pathways: the transcellular and the paracellular pathway. The transcellular 
pathway is involved in the transport of nutrients, including sugars, amino 
acids, peptides, fatty acids, minerals and vitamins. As the cell membrane is 
impermeable, this process is predominantly mediated by specific transporters 
and channels (Fig. 2) located on the apical and basolateral membranes. The 
paracellular pathway is associated with diffusion though the intercellular 
space between adjacent epithelial cells. Therefore, the ability of the intestinal  
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Figure 2. Schematic representation of simple diffusion and mediated transport 
mechanisms. 
 
epithelium to establish the equilibrium between nutrient absorption and the 
prevention of harmful element entry constitutes the key backbone of 
intestinal barrier function. In addition, other elements also contribute to 
mucosal protection, such as the luminal mucus layer, antibacterial products 
and microbiota which not only protects against pathogens but also forms a 
sophisticated intestinal homeostatic colonization system, as well as 
intraepithelial lymphocytes and subepithelial immune cells with innate and 
adaptive immune systems [23].  
 The structural integrity of the epithelium is maintained by three distinct 
adhesion systems: tight junctions (TJ), adherent junctions, and desmosomes. 
The adherent junctions, along with desmosomes, provide strong adhesive bonds 
between the epithelial cells and also aid intercellular communication, but does 
not determine paracellular permeability (PP) [24]. TJ, the most apical 
component, are the rate-limiting step for PP and constitute the interface (fence) 
between apical and basolateral membrane domains [25]. TJ are formed by 
transmembrane proteins associated with cytosolic proteins and the cytoskeletal 
perijunctional actomyosin ring (Fig. 3). Five transmembrane proteins of the TJ 
have been identified until now: occludin, the claudin family, tricellulin, crumbs, 
and junctional adhesion molecules (JAM). These proteins are associated with a 
wide spectrum of cytosolic proteins, of which zonula occludens (ZO)-1, ZO-2, 
ZO-3, AF6, and cingulin are described as forming the nexus with cytoskeletal 
proteins [26]. Although the structure and in some cases the role of these 
proteins have been well described, the manner they work together to determine 
selective PP is not already completely well-defined [27].  
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Figure 3. Molecular structure of the tight junction (TJ) of intestinal epithelial cells. 
The TJ complex consists of transmembrane and intracellular scaffold proteins. The 
extracellular loops of the transmembrane proteins (occludin, claudins, JAMs, and 
tricellulin) create a selective barrier in the paracellular pathway. The intracellular 
domains of the transmembrane proteins interact with the intracellular scaffold proteins 
such as zonula occludens (ZO) proteins and cingulin, which in turn anchor the 
transmembrane proteins to the actin cytoskeleton.  
 
2. Disruption of the intestinal epithelial barrier function  
 
 The modification of TJ structure and therefore PP is dynamically 
regulated by various extracellular stimuli and is closely associated with 
health and susceptibility to disease [28]. In this sense, evidence from basic 
science and clinical studies indicate that the intestinal TJ barrier has a critical 
role in the pathogenesis of intestinal diseases such as inflammatory bowel 
disease, celiac disease and irritable bowel syndrome [28]. TJ barrier 
disruption and increased PP, followed by permeation of luminal 
proinflammatory molecules, can induce activation of the mucosal immune 
system, resulting in sustained inflammation and tissue damage. Thus, pro-
inflammatory cytokines, antigens, and pathogens contribute to barrier 
impairment [29]. In contrast, food factors and nutrients also participate in 
intestinal TJ regulation, and some of these could be developed as preventive 
and therapeutic tools for defective barrier-associated diseases [30]. 
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 Tumour Necrosis Factor-α (TNF-α), mainly produced by activated 
macrophages and T lymphocytes, has been described to be one of the main 
cytokines involved in the disruption of epithelial barrier function in intestinal 
inflammatory processes [31]. TNF-α regulates barrier function indirectly by 
the generation of oxidative stress and directly via an increase in myosin light 
chain kinase (MLCK) expression and activity [32,33] and TJ remodelling 
[34]. In this regard, MLCK activation triggers different cellular contractile 
events including a) occludin endocytosis to the cytosol leading to the 
disorganization of the TJ, and the b) contraction of the perijunctional 
actomyosin which generates mechanical tension at the TJ and induces its 
opening [35]. In fact, all these effects of TNF-  on TJ structure and 
permeability are prevented by genetic or pharmacological MLCK inhibition, 
as is diarrhea [32]. This highlights the close link between changes in TJ, 
epithelial barrier disruption and water loss. 
 The production of reactive oxygen and nitrogen species (ROS and RNS) 
has gained relevance in recent years in the context of the regulation of TJ 
permeability. In Caco-2 cells, H2O2 has been reported to induce the 
dissociation of the complex formed by occludin and ZO-1 and the separation 
of this complex from the cytoskeleton via a Tyr kinase-dependent mechanism 
[36]. This effect is accompanied by the disorganization of actin and the 
redistribution of occludin and ZO-1 from the TJ to the cytosol [37]. In this 
sense, the increased production of ROS has also been reported to play an 
important role in a number of intestinal disorders including inflammatory 
bowel disease [38]. Moreover, a significant body of evidence suggests that 
oxidative stress disrupts epithelial barrier function [39]. Indeed, the protective 
role of many substrates with antioxidant properties (such as taurine, quercetin 
and epithelial growth factors) has been proven as useful in TJ sealing [40-42]. 
 
3. Evaluation of epithelial barrier function 
 
 Experimentally, TJ barrier integrity and permeability in intestinal tissues 
and cells are evaluated by measurement of transepithelial electrical resistance 
(TER) and the paracellular passage of water soluble molecules of different 
molecular weight, such as mannitol, dextran, and inulin. The use of cultures 
of intestinal epithelial cells (Caco-2, IEC-6, HT-29, T-84, etc.) is frequently 
used as a reductionist experimental model to evaluate epithelial barrier 
function. The cells are allowed to grown on to semipermeable filters to create 
an apical and a basolateral compartment to measure transepithelial fluxes of 
paracellular markers and TER [43-45]. The tightness of the monolayer is 
indicated by high TER values and low permeability to paracellular markers. 
TER is considered an indicator of ionic fluxes across the epithelium or cell 
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monolayer (mainly Na
+
 and Cl
-
). In addition to charge selectivity, TJ differ in 
size selectivity. In this sense, it is described a pore pathway that is permeable 
to molecules with radii of 4 Å or less and a second pathway, which is refered 
to as the leak pathway, for flux of larger noncharged solutes [27]. The small 
ions do not discriminate between pore and leak pathways, and therefore TER 
cannot be used to investigate the selectivity of TJ size or charge. Increased 
permeability of both pathways reduces TER values. The permeability of the 
leak pathway is then evaluated from transepithelial fluxes of paracellular 
markers. In cells in culture the more commonly used tracers include                     
D-mannitol, sucrose, inulin, PEG or dextrans of different molecular                 
weights [27].  
 The Caco-2 cell system is an efficient model to study the changes in 
epithelial barrier function induced by several infectious microorganisms that 
are also involved in gastrointestinal disorders, such as rotavirus, Escherichia 
coli, Vibrio parahaemolyticus and Salmonella [46-49]. Moreover, the role of 
the toll-like receptor 2 pathway, which plays a key role in microbial 
recognition and immune modulation in the regulation of TJ permeability, has 
also been described in this experimental model [50]. Similarly, the protective 
effect of probiotics, such as Lactobacillus rhamnosus and Lactobacillus 
casei, against the effect of pro-inflammatory cytokines has also been 
demonstrated in Caco-2 cells [51,52]. In this sense, intestinal cells in culture, 
mainly Caco-2 cells, can also be co-cultured with different immune cells to 
also consider the mechanisms of cellular interaction in the regulation of TJ 
permeability [53].  
 
4. Intestinal epithelial barrier function disruption by 
Salmonella: Nutritional strategies to prevent this effect 
 
 The invasion of Salmonella Enteritidis into the intestinal epithelium 
triggers diverse transduction signals at the subepithelial compartment which 
induce the activation of immune cells and therefore the onset of the 
inflammatory process [14]. The secretion of proinflammatory cytokines 
disrupts epithelial barrier function which in turn contributes to water loss and 
bacterial translocation, perpetuating the inflammatory process and initiating 
systemic invasion [35]. In this sense, the infection of cultures of human 
intestinal Caco-2 cells with different strains of Salmonella confirms the 
ability of these bacteria to increase PP [48]. This is exemplified through a 
decrease in TER, increase in tracer permeability and TJ protein alterations 
when assessed in a variety of cell lines including MDCK, Caco-2 and T84 
cells [54-56]. In this regard, it has been concluded that Salmonella causes a 
decrease in both ZO-1 expression and in the amount of phosphorylated 
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occludin in the TJ by 2 h of T84 cell infections [56]. Studies aimed at 
elucidating the specific bacterial proteins involved in the documented 
Salmonella-induced TJ alterations have primarily used mutated strains of 
Salmonella to identify those that do not alter TER, ZO-1 and occludin 
localization. Through these experiments, the SPI1 effectors; SopB, SopE, 
SopE2 and SipA have all been implicated in TJ alterations [57]. Moreover, 
since Salmonella infection induces an increase in TNF-α production [58,59], 
the effect of infection on PP can be, almost in part, attributed to this cytokine. 
This suggests that synergistic and potentially redundant mechanisms are in 
place to ensure TJ are modified as part of the disease imparted by Salmonella. 
Since 2006, the use of antibiotics as chicken growth promoters has been 
baned (January, 1, 2006; Regulation 1831/2003 of the European Parliament 
and of the Council). This prohibition arises from the increase of antibiotic 
resistant bacteria in animal farms and represents a health hazard after 
resistance transfer to human pathogenic bacteria [3]. For this reason, 
extensive research has been conducted on the development of naturally 
occurring antimicrobials as alternatives to antibiotics. In this sense, probiotic 
and prebiotic feed additives are promising alternatives because they control 
intestinal microbiota, reducing pathogenic bacteria colonization and 
enhancing mucosal immune system [60]. 
 Probiotics are generally referred to as any live microbial feed 
supplements that benefit the host animals by largely improving intestinal 
microbial balance [61]. Intestinal microorganisms that are recognized as 
possessing probiotic properties include mainly Lactobacilli and 
Bifidobacteria spp. They exhibit identifiable beneficial effects for the 
respective host via promotion of gut maturation and integrity, antagonism 
against pathogens such as Salmonella and immune modulation [62]. The 
effects of probiotics in poultry also include maintaining normal intestinal 
microflora by competitive exclusion, increasing metabolism, decreasing 
enzymatic activity and ammonia production, as well as an increase in feed 
intake and the neutralization of digestive enterotoxins [63]. Therefore, the 
overall goal of probiotics intervention is to promote the general growth of 
healthy microorganisms that are competitive with or antagonistic to 
enteropathogens [61]. 
 Prebiotics can be defined as non-digestible carbohydrate fractions fed 
in diets that are beneficial to the host by stimulating the growth of one or 
more bacteria in the gastrointestinal tract [64]. Prebiotics are predominantly 
a constituent of plant cell walls and also consist of non-starch 
polysaccharides along with non-carbohydrate compounds including lignin, 
protein, fatty acid, and wax [65]. Dietary β-galactomannans are non 
digestible complexes used as prebiotics due to their ability to confer 
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favourable conditions to intestinal beneficial Lactobacillus. Taking into 
account that Salmonella express mannose-specific lectins involved in the 
adherence of these bacteria to the intestinal epithelium [66],                                
β-galactomannans show competition thus preventing Samonella 
colonization. The main source of β-galactomannans is the cell walls of 
Saccharomyces cerevisiae which contain 45% of mannose residues [67]. 
However, new sources are being investigated. In this sense, IRTA, the 
Research and Technology Food and Agriculture Institute from the 
Generalitat de Catalunya, has developed a food additive extract from the 
carob bean of the Ceratonia silliqua tree (Salmosan®) which 
approximately contains 88% of β-galactomannans [68]. We have reported, 
in cultures of intestinal pig cells (IPI-2I), the capacity of Salmosan® to 
inhibit Salmonella Typhimurium epithelial attachment and to reduce up to 
70% Salmonella-induced mRNA expression of proinflammatory cytokines 
such as TNF-α, GM-CSF (Granulocyte/Macrophage Colony-Stimulating 
Factor) and chemokine CCL20 [59]. These results are very similar to the 
obtained for Sacharomyces cerevisiae used as a positive control. Moreover, 
scanning electron microscopy images obtained in our laboratory confirm 
that the capacity of Salmosan® to reduce Salmonella adhesion in these 
experimental conditions is due to bacterial attachment to this prebiotic [59] 
(Fig. 4).  
 
A B C
 
 
Figure 4. Interaction of Salmonella Typhimurium with Salmosan® on the surface of 
IPI-2I cells assessed by scanning electron microscopy. Images show Salmonella 
attachment on epithelial cells (A), Salmosan® over the control cells (B), and 
Salmonella interaction with Salmosan® (C).  
 
5. Conclusion 
 
 Foodborne pathogens such as Salmonella possess the capability to 
survive in external environments during transmission from one host to the 
next. The determination of microbial genetics and physiology associated with 
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these mechanisms could have great potential for better control of pathogen 
colonization. In this sense, although advances have led to an overall greater 
understanding, the detailed mechanisms that these microorganisms employ to 
modify TJ remain elusive. For this reason, a better understanding of these 
indicators could assist in designing more novel approaches to minimize the 
spread of Salmonella in the food animal industry and decrease the 
consequences to human health. 
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